Gastro Esophageal Reflux Disease
9
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Endoscopic Treatment of Gastroesophageal Reflux Disease
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
The Effect of Postural Correction On Gastroesophageal Reflux Disease
Kazakh Version of Reflux Symptom Index
Spirulina Platensis for PPI Withdrawal
Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy
Endoscopic Full Thickness Plication (GERD-X) for the Treatment of PPI Dependent GERD:
Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance
Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance (Encore)